These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Corosolic acid analogue, a natural triterpenoid saponin, induces apoptosis on human hepatocarcinoma cells through mitochondrial pathway in vitro. Qu L; Zhang H; Yang Y; Yang G; Xin H; Ling C Pharm Biol; 2016 Aug; 54(8):1445-57. PubMed ID: 26810384 [TBL] [Abstract][Full Text] [Related]
43. CIDE-3 interacts with lipopolysaccharide-induced tumor necrosis factor, and overexpression increases apoptosis in hepatocellular carcinoma. Min J; Zhang W; Gu Y; Hong L; Yao L; Li F; Zhao D; Feng Y; Zhang H; Li Q Med Oncol; 2011 Dec; 28 Suppl 1():S219-27. PubMed ID: 20957525 [TBL] [Abstract][Full Text] [Related]
44. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy. Jin F; Wang Y; Li M; Zhu Y; Liang H; Wang C; Wang F; Zhang CY; Zen K; Li L Cell Death Dis; 2017 Jan; 8(1):e2540. PubMed ID: 28079894 [TBL] [Abstract][Full Text] [Related]
45. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3. Chen KF; Chen HL; Liu CY; Tai WT; Ichikawa K; Chen PJ; Cheng AL Biochem Pharmacol; 2012 Mar; 83(6):769-77. PubMed ID: 22230479 [TBL] [Abstract][Full Text] [Related]
46. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity. Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739 [TBL] [Abstract][Full Text] [Related]
47. Bafilomycin A1 induces caspase-independent cell death in hepatocellular carcinoma cells via targeting of autophagy and MAPK pathways. Yan Y; Jiang K; Liu P; Zhang X; Dong X; Gao J; Liu Q; Barr MP; Zhang Q; Hou X; Meng S; Gong P Sci Rep; 2016 Nov; 6():37052. PubMed ID: 27845389 [TBL] [Abstract][Full Text] [Related]
48. Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma Cells. Saha SK; Yin Y; Kim K; Yang GM; Dayem AA; Choi HY; Cho SG Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498322 [TBL] [Abstract][Full Text] [Related]
49. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Ding ZB; Shi YH; Zhou J; Qiu SJ; Xu Y; Dai Z; Shi GM; Wang XY; Ke AW; Wu B; Fan J Cancer Res; 2008 Nov; 68(22):9167-75. PubMed ID: 19010888 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of autophagy in hepatocarcinoma cells promotes chemotherapeutic agent-induced apoptosis during nutrient deprivation. Guo XL; Hu F; Wang H; Fang JM; Zhu ZΖ; Wei LΧ; Xu Q Oncol Rep; 2018 Feb; 39(2):773-783. PubMed ID: 29207161 [TBL] [Abstract][Full Text] [Related]
51. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells. Peng YF; Shi YH; Ding ZB; Ke AW; Gu CY; Hui B; Zhou J; Qiu SJ; Dai Z; Fan J Autophagy; 2013 Dec; 9(12):2056-68. PubMed ID: 24157892 [TBL] [Abstract][Full Text] [Related]
52. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma. Li W; Wang M; Wang L; Ji S; Zhang J; Zhang C Cell Biochem Biophys; 2014 Mar; 68(2):427-36. PubMed ID: 23975599 [TBL] [Abstract][Full Text] [Related]
53. Iron deprivation suppresses hepatocellular carcinoma growth in experimental studies. Ba Q; Hao M; Huang H; Hou J; Ge S; Zhang Z; Yin J; Chu R; Jiang H; Wang F; Chen K; Liu H; Wang H Clin Cancer Res; 2011 Dec; 17(24):7625-33. PubMed ID: 22052937 [TBL] [Abstract][Full Text] [Related]
54. Influence of distant tumor growth and lithium treatment on ultrastructural organization of kidney proximal tubules. Bgatova N; Taskaeva I; Makarova V Ultrastruct Pathol; 2021 May; 45(3):212-223. PubMed ID: 34304707 [TBL] [Abstract][Full Text] [Related]
56. Lithium Enhances Autophagy and Cell Death in Skin Melanoma: An Ultrastructural and Immunohistochemical Study. Taskaeva I; Gogaeva I; Shatruk A; Bgatova N Microsc Microanal; 2022 May; ():1-9. PubMed ID: 35592888 [TBL] [Abstract][Full Text] [Related]
57. Effect of a New Lithium Preparation on the Behavior of CBA/CaLac Mice in an Experimental Conflict Model. Korolev MA; Madonov PG; Rachkovskaya LN; Suslov NI; Shurlygina AV; Rachkovskii EE; Robinson MV; Kotlyarova AA; Popova TV; Povet'eva TN; Afanas'eva OG; Nesterova YV; Letyagin AY Bull Exp Biol Med; 2021 Feb; 170(4):436-439. PubMed ID: 33713221 [TBL] [Abstract][Full Text] [Related]
58. Lithium: A Promising Anticancer Agent. Villegas-Vázquez EY; Quintas-Granados LI; Cortés H; González-Del Carmen M; Leyva-Gómez G; Rodríguez-Morales M; Bustamante-Montes LP; Silva-Adaya D; Pérez-Plasencia C; Jacobo-Herrera N; Reyes-Hernández OD; Figueroa-González G Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836894 [TBL] [Abstract][Full Text] [Related]
59. Effects of lithium on magnetic resonance imaging signal might not preclude increases in brain volume after chronic lithium treatment. Vernon AC; Hajek T Biol Psychiatry; 2013 Dec; 74(12):e39-40. PubMed ID: 23998561 [No Abstract] [Full Text] [Related]
60. Reply to: effects of lithium on magnetic resonance imaging signal might not preclude increases in brain volume after chronic lithium treatment. Ferrier NI; Blamire AM; Cousins DA Biol Psychiatry; 2013 Dec; 74(12):e41-2. PubMed ID: 23993640 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]